BridgeMD
New treatment option for Infertility
Official title Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score
ClinicalTrials.gov ID: NCT07020546
What this study is testing
- What it's testing
- Patients will have ovarian PRP treatments and embryo development will be observed using time-lapse imaging and AI software.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 47, women only. Healthy volunteers may be eligible.
You may be able to join if
- No none contraindications to IVF or PRP treatment
- Adequate ovarian reserves and AMH level
- Willingness to undergo two IVF cycles and oPRP treatment
You likely can't join if
- Anovulation due to menopause or perimenopause
- Any health conditions that are contraindicated for IVF or oPRP treatment
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 47 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.